Submission of a draft resolution on matters on the agenda of the Extraodrinary General Meeting of Medicalgorithmics S.A. convened for 22 March 2022
Current Report No 13/2022
Legal basis: Article 56(1)(2) of the Act on Public Offering – current and periodical information
The Management Board of Medicalgorithmics S.A. (“Company”) informs that on March 19, 2022. The Company received from a shareholder of the Company, Marek Dziubinski, representing at least one twentieth of the share capital of the Company, a notification of draft resolutions for the Extraordinary General Meeting of the Company convened for 22 March 2022 (current report No. 09/2022 of 23 February 2022) to items 7 and 8 of the agenda, providing for adoption of resolutions on:
- (i) increasing the Company’s share capital through the issuance of new series I ordinary bearer shares and depriving existing shareholders in full of their pre-emptive rights to all new series I shares, (ii) dematerialization and applying for the admission (ii) dematerialization and applying for admission and introduction of new series I shares and series I shares allotment certificates to trading on the regulated market of the Warsaw Stock Exchange, and (iii) amendment to the Company’s Articles of Association.
- introduction in the Company of an Incentive Scheme, a conditional increase of the share capital of the Company and the issue of subscription warrants with complete exclusion of the pre-emptive right of shareholders to subscription warrants and shares issued within the scope of conditional capital and amendment of the Articles of Association, dematerialisation and applying for admission and introduction of shares issued within the scope of conditional capital to trading on a regulated market operated by Giełda Papierów Wartościowych w Warszawie S.A.
The received draft resolutions are attached to this report.